APA (7th ed.) Citation

Y, C., X, L., L, Z., Y, L., H, C., L, L., . . . B, G. (2026). An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer. Frontiers in immunology, 17, 1808490. https://doi.org/10.3389/fimmu.2026.1808490

Chicago Style (17th ed.) Citation

Y, Chen, Lu X, Zhang L, Li Y, Chen H, Luo L, Pan Y, and Gao B. "An Anoikis-related Gene Signature Predicts Prognosis and Immunotherapy Response, and Identifies CCAR2 as a Therapeutic Target in Triple-negative Breast Cancer." Frontiers in Immunology 17 (2026): 1808490. https://doi.org/10.3389/fimmu.2026.1808490.

MLA (9th ed.) Citation

Y, Chen, et al. "An Anoikis-related Gene Signature Predicts Prognosis and Immunotherapy Response, and Identifies CCAR2 as a Therapeutic Target in Triple-negative Breast Cancer." Frontiers in Immunology, vol. 17, 2026, p. 1808490, https://doi.org/10.3389/fimmu.2026.1808490.